Updates From Trial of AveXis SMA1 Gene Therapy Trial Show Impressive Results in Most Infants – SMA News Today
SMA News Today |
Updates From Trial of AveXis SMA1 Gene Therapy Trial Show Impressive Results in Most Infants
SMA News Today Results from the first clinical trial of AVXS-101, a gene therapy for infants with spinal muscular atrophy (SMA) type 1, reveal dramatically improved survival as well as motor skills in most of the babies involved in the drug’s first clinical trial … |
Blasting News |
CRISPR and Stem Cells Identify Novel Chlamydia Drug Targets
Genetic Engineering & Biotechnology News They used a combination of gene-editing and stem cell technologies to make the model that helped lead to the discovery of two genes from our immune system, interferon regulatory factor 5 (IRF5) and interleukin-10 receptor subunit alpha (IL-10RA), as … Scientists discover new chlamydia drug targets by stem cellsBlasting News |
|
BeneVir Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H and Other Platform Assets
Yahoo Finance 9,623,059, entitled “Oncolytic Herpes Simplex Virus and Therapeutic Uses Thereof”, covering the composition of matter for Stealth-1H, BeneVir’s lead oncolytic immunotherapy, as well as other platform assets. BeneVir is a portfolio company within … |
|
BeneVir Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H and Other Platform Assets
Yahoo Finance 9,623,059, entitled “Oncolytic Herpes Simplex Virus and Therapeutic Uses Thereof”, covering the composition of matter for Stealth-1H, BeneVir’s lead oncolytic immunotherapy, as well as other platform assets. BeneVir is a portfolio company within … |
Slate Magazine |
Synthetic Biology and Queer Theory Are Cutting Down the “Tree of Life” You Learned About in School
Slate Magazine To return to our original question, where might a synthetic microbe fit into such biological taxonomies? In her work The Synthetic Kingdom, artist Alexandra Daisy Ginsberg suggests, “We will have to insert an extra branch into the Tree of Life. The … |